Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients.
暂无分享，去创建一个
T. Marron | M. Schwartz | M. Cedillo | B. Marinelli | Edward Kim | R. Lookstein | A. Fischman | S. Pasik | V. Bishay | M. Sung | S. Nowakowski | S. Murthy | D. Charles | R. Patel | M. Ranade